Gates Foundation, U.K. Government Pledge $52M To CARB-X To Accelerate Research Into New Antibiotics

STAT: Gates Foundation and U.K. put $52 million toward project fighting drug-resistant bacteria
“A transatlantic initiative devoted to underwriting new antibiotics and other treatments to tackle drug-resistant infections in developing countries received a big boost today when the Bill & Melinda Gates Foundation and the U.K. government agreed to fund the effort. The CARB-X project, which was created two years ago and later secured $455 million in funding from the U.S. government and a public-private partnership in the U.K., is now slated to receive an additional $52 million that will also be invested in getting new treatments into humans in clinical trials…” (Silverman, 5/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.